Riparian Pharmaceuticals Secures Exclusive License Agreement with Pfizer for Cardiovascular Program
US-based Riparian Pharmaceuticals, Inc., a biotechnology company focused on cardiovascular diseases and co-incubated by Viva...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity